Pharmaceutical excipient development: The need for preclinical guidance

Regulatory Toxicology and Pharmacology

Volumn 32, Issue 2, 2000, Pages 210-218

  Baldrick, Paul ^a  

^a UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EXCIPIENT; FOOD ADDITIVE;

ARTICLE; DRUG FORMULATION; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0033732478     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.2000.1421     Document Type: Article

References (67)

1. A review of unique male rat hydrocarbon nephropathy
2. An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane)
3. 'Inactive' ingredients in pharmaceutical products: Update
4. A toxicological review of lactose to support clinical administration by inhalation
5. Pharmaceutical excipient testing - A regulatory and preclinical perspective
6. Sugars and adrenomedullary proliferative lesions: The effects of lactose and various polyalcohols
7. Significance of Leydig cell neoplasia in rats fed lactitol or lactose
8. Place of excipients in drug-related allergy
9. An evaluation of genotoxicity tests with Aquateric aqueous enteric coating
10. Evaluation of a non-chlorofluorocarbon formulation of cromolyn sodium (Intal) metered-dose inhaler versus the chlorofluorocarbon formulation in the treatment of adult patients with asthma: A controlled trial
11. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation
12. Cell proliferation and carcinogenesis
13. Considerations for toxicology studies of respiratory drug products
14. The safety of pharmaceutical excipients
15. Absorption of polyethylene glycols 600 through 2000: The molecular weight dependence of gastrointestinal and nasal absorption
16. The human relevance of the renal tumor-inducing potential of d-limonene in male rats: Implications for risk assessment
17. The parthogenesis of reticulo-endothelial foam cells: Effect of polyvinylpyrrolidone on the liver of the mouse
18. Pharmaceutical excipients: Adverse effects associated with 'inactive' ingredients in drug products (Part II)
19. An analysis of the National Toxicology Program's (NTP) Technical Report (NTP TR 421) on the toxicology and carcinogenesis studies of talc
20. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers
21. Teratogenic evluation of alternative vehicles: PEG 400, cremophor, carboxy-methylcellulose - Comparisons with methylcellulose
22. Twenty-eight-day double-blind safety study of an HFA-134a inhalation aerosol system in healthy subjects
23. Novel excipients for sugar-free preparations - Functionality and performance
24. Single- and repeated-dose local toxicity in the nasal cavity of rabbits after intranasal administration of different glycols for formulations containing benzodiazepines
25. Chitosan and its use as a pharmaceutical excipient
26. Transferrin conjugated PEG-liposomes as intracellular targeting carrier for tumor therapy
27. Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations
28. Multivesicular liposome (DepoFoam) technology for the sustained delivery of Insulin-like Growth Factor-I (IGF-I)
29. Subchronic toxicity and development toxicity studies in rats with Aquateric aqueous enteric coating
30. D-Limonene-induced male rat-specific nephrotoxicity: Evaluation of the association between D-limonene and α(2μ)-globulin
31. Low digestible carbohydrates (polyols and lactose): Significance of adrenal medullary proliferative lesions in the rat
32. Complexation and cyclodextrins
33. Erythritol: An interpretive summary of biochemical, metabolic, toxicological and clinical data
34. Pathological changes in rabbits from repeated intravenous injections of Periston (polyvinyl pyrrolidone) or dextran
35. Excipients: Their role in parenteral dosage forms
36. Design of a 'microbicide' for prevention of sexually transmitted diseases using 'inactive' pharmaceutical excipients
37. Medicinal products for human use, presentation and content of the dossier
38. Developmental toxicity study of Aquacoat ECD ethylcellulose aqueous dispersion administered orally to rats
39. Evaluation of the effect of polyethylene glycol 400 on the nasal absorption of nicardipine and verapamil in the rat
40. Povidone-iodine liposomes - An overview
41. Regulatory issues with excipients
42. Relevance for man of the effects of lactose, polyols and other carbohydrates on calcium metabolism seen in rats: A review
43. Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: Influence of liposome characteristics
44. Developments in tablet excipients since 1960
45. The sensitisation potential of some perfume ingredients tested using a modified Draize procedure
46. A new approach to the safety assessment of pharmaceutical excipients
47. Poly (lactic/glycolic acid) microspheres containing antigen as a novel and potential agent of immunotherapy for allergic disorders
48. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration
49. Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals in drug formulations
50. Immunoliposomes and PEGylated immuno-liposomes: Possible use for targeted delivery of imaging agents
51. Regulatory status of excipients in Japan
52. Teratogenic effects of polyethylene glycol 200 in the mouse but not in the rat
53. A compendium of vaccine adjuvant and excipients
54. Toxicologic testing of inhaled pharmaceutical aerosols
55. Saccharin mechanistic data and risk assessment: Urine composition, enhanced cell proliferation, and tumour promotion
56. Contrast medium- and mannitol-induced apoptosis in heart and kidney of SHR rats